Valeant's (VRX) Salix Announces FDA Approval For PLENVU
Valeant Pharmaceuticals (NYSE: VRX) subsidary Salix Pharmaceuticals, Ltd. and its partner Norgine B.V. announced today that the U.S. Food and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
